The Nucleocapsid Protein of Rift Valley Fever Virus Is a Potent Human CD8+ T Cell Antigen and Elicits Memory Responses-Reference-Cited by-同舟云学术

The Nucleocapsid Protein of Rift Valley Fever Virus Is a Potent Human CD8+ T Cell Antigen and Elicits Memory Responses

Published:2013-03-18 Issue:3 Volume:8 Page:e59210
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Xu Weidong,Watts Douglas M.,Costanzo Margaret C.,Tang Xiaolei,Venegas Leon A.,Jiao Feng,Sette Alessandro,Sidney John,Sewell Andrew K.,Wooldridge Linda,Makino Shinji,Morrill John C.,Peters Clarence J.,Kan-Mitchell June

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference86 articles.

1. Rift valley fever: recent insights into pathogenesis and prevention;H Boshra;J Virol,2011

2. Rift Valley Fever in Man : Report of a Fatal Laboratory Infection Complicated by Thrombophlebitis;FF Schwentker;The Journal of experimental medicine,1934

3. Rift Valley Fever : A Report of Three Cases of Laboratory Infection and the Experimental Transmission of the Disease to Ferrets;T Francis;The Journal of experimental medicine,1935

4. Rift Valley fever; accidental infections among laboratory workers;KC Smithburn;J Immunol,1949

5. Manifestations of severe Rift Valley fever in Sudan;AA Adam;Int J Infect Dis,2010

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Minimal Protective Antibody Titers Elicited in Sheep by RVFV MP-12 and arMP-12ΔNSm21/384 Vaccine Candidates;International Journal of Veterinary Science and Research;2024-08-03

2. The Adaptive Immune Response against Bunyavirales;Viruses;2024-03-21

3. Advances and perspectives in the development of vaccines against highly pathogenic bunyaviruses;Frontiers in Cellular and Infection Microbiology;2023-05-18

4. Immunization with a small fragment of the Schmallenberg virus nucleoprotein highly conserved across the Orthobunyaviruses of the Simbu serogroup reduces viremia in SBV challenged IFNAR-/- mice;Vaccine;2023-05

5. An Overview of Rift Valley Fever Vaccine Development Strategies;Vaccines;2022-10-25